Improvement in quality of life after robotic surgery results in patient satisfaction

Abstract

BackgroundThere are well-described benefits to minimally invasive surgery including decreased blood loss, shorter hospital-stay, and faster recovery. The role of robotic surgery in gynecologic oncology has become increasingly prominent; however limited data are available on quality of life (QOL) after robotic surgery. MethodsIn this prospective, IRB-approved study, women scheduled for robotic surgery for a gynecologic indication between May 2008 and February 2012 completed validated QOL measures at baseline, 6weeks (6wk), and 4months postoperative (4mo). Functional status (SF-12), symptom severity and interference (MDASI), sexual function (FSFI), and satisfaction with decision (SWD) were assessed at relevant time points. Differences between groups were evaluated using the Mann–Whitney test. ResultsAmong 408 women who underwent robotic surgery 278 (68%) completed the QOL measures. Median age was 55.6years (range 25.7–85.1). Median BMI was 31.3kg/m2. The majority of patients were white (75%). The most common indication for surgery was endometrial cancer/hyperplasia (59.7%). While physical functioning declined from baseline to 6wk (51.4 to 41.6, p<0.001), it improved by 4mo (53.5). Mental functioning improved over time (baseline 48.6, 6wk 52.8, and 4mo 55.6, p<0.001). Symptom severity decreased over time (p<0.001) as did symptom interference (p<0.001). Sexual function improved significantly from baseline (8.6) to 4mo (20.2, p<0.001). Patients were satisfied with their decision making (SWD=30). ConclusionIn this prospective study, general health, symptom burden and sexual function returned to or improved beyond baseline levels within 6weeks of surgery. Overall, women were satisfied with their decision to undergo robotic surgery.